Article
Evaluation of a Phenotypic Algorithm to Direct Carbapenemase Testing in Pseudomonas aeruginosa: Validation in a Multicenter German Cohort.
Microbial drug resistance (Larchmont, N.Y.) - 1 Sept 2021
Gill Christian M, Kresken Michael, Seifert Harald, Nicolau David P
Abstract excerpt
Pseudomonas aeruginosa remains a prominent nosocomial pathogen. Detection of carbapenemase-producing P. aeruginosa is vital to dictate antimicrobial therapy and infection control measures. A pragmatic, minimum inhibitory concentration-based algorithm using imipenem AND meropenem-resistant plus ceftazidime-, cefepime-, and piperacillin/tazobactam-nonsusceptible criterion was derived to guide carbapenemase testing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
